All locations are open. Call your doctor today to schedule an in-person appointment or a doctor video visit.
Learn about our COVID-SAFE Care • Latest Visitor Policy and Service Updates • Donate and Lend Support


Todos los centros abiertos. Llame al médico hoy para una cita en persona o para una video visita médica.
Sepa qué es la Salud A SALVO DE COVID • Novedades de servicios y normas de visitas • Done y dé apoyo

Learn more
Search Clinical Trials
Home >  Clinical Trials & Research >  Search Clinical Trials
Print

Clinical Trials & Research

Search Clinical Trials

Clinical Trials

New Search
Title   A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, and the Combination of Cediranib/Olaparib in Women With Recurrent, Persistent or Metastatic Endometrial Cancer
Disease/Condition   Obstetrics & Gynecology and Women`s Health,Urologic Oncology (Med Onc),Cancer,Carcinoma,Urogenital Neoplasms
Description  

Click here for more information

Eligibility Criteria   Click here for eligibility requirements
Principal Investigator   Nicole Nevadunsky, MD
Contact Name   Meghan Proehl
Contact Email   mproehl@montefiore.org
Protocol Number   2018-9876
Inclusion/Notes   This Information was obtained from ClinicalTrials.gov
Status   Active/Enrolling
Adult Clinical Trial   Yes
Pediatric Clinical Trial   No
Sub-Specialty   Cancer-Related Endometrial
Adult, Pediatric, Both   Adult